N-Phenyl-N'-pyridinylureas as Anticonvulsant Agents

Journal of Medicinal Chemistry

Volumn 33, Issue 2, 1990, Pages 854-861

  Pavia, Michael R ^a   Lobbestael, Sandra J ^a   Taylor, Charles P ^a   Hershenson, Fred M ^a   Miskell, David L ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 CHLORO 6 METHYLPHENYL) 3 (4 PYRIDYL)UREA; 1 PHENYL 3 (4 PYRIDYL)UREA DERIVATIVE; PHENYTOIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG SCREENING; DRUG SYNTHESIS; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEIZURE; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, ORAL; ANIMAL; ANTICONVULSANTS; ATAXIA; CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; PHENYLUREA COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0025057988     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00164a061     Document Type: Article

References (27)

1. Presented in part at 194th American Chemical Society Meeting, New Orleans, LA, 1987.
2. Coatsworth, J. J. NINCDS Monograph No. 12; Government Printing Office: Washington, DC, 1971.
3. Porter, R. J.; Penry, J. K. Advances in Epileptology, 1977: Psychology, Pharmacotherapy and New Diagnostic Approaches; Meinardi, H., Rowan, A. J., Eds.; Swets and Zeitlinger: Amsterdam, 1978; p 220.
4. Gallagher, B. B. In Anticonvulsants, Vida, J. A., Ed.; Academic: New York, 1977; p 11.
5. Wilder, B. J.; Bruni, J. Seizure Disorders—A Pharmacological Approach to Treatment, Raven: New York, 1981; pp 1 and 23.
6. Brooker, H. E. Epilepsia (N.Y.) 1975, 16, 171.
7. Eadie, M. J. The Treatment of Epilepsy, Tyrer, J. H. Ed.; MTP Press: Lancaster, 1980; p 129.
8. Schmidt, D. In Antiepileptic Drugs, Handbook of Experimental Pharmacology; Frey, H. H., Jahz, D., Eds.; Springer Verlag: Berlin, 1985; Vol. 74, p 791.
9. Schmidt, D.; Sheldon, L. Adverse Effects of Antiepileptic Drugs; Raven: New York, 1982; p 3.
10. Kupferberg, H. J.; Gladding, G. D.; Swinyard, E. A. In ref 4c p 341.
11. Lobbestael, S. J.; Nordin, I. C.; Fleming, R. US Patent 4, 629,731, 1986. Chem. Abstr. 103, P71195Y.
12. Okamoto, T.; Isotani, H.; Kuto, K.; Sato, S. Japanese Patent 581/194804, 1983. Chem. Abstr. 100, 98322n.
13. Tanimoto, S.; Harada, H. Plant Cell Physiol. 1982, 23, 1371.
14. Okamoto, T.; Shudo, K.; Takahashi, S.; Kawachi, E.; Isogai, Y. Chem. Pharm. Bull. 1981, 29, 3748.
15. Takahashi, S.; Shudo, K.; Okamoto, T.; Yamada, K.; Isogai, Y. Phytochemistry 1978, 17, 1201.
16. Hardy, D. V. N. J. Chem. Soc. 1934, 2011.
17. Chambers, J.; Reese, C. B. Tetrahedron Lett. 1975, 2783.
18. Kurita, K.; Matsuma, T.; Iwakura, Y. J. Org. Chem. 1976, 41, 2070.
19. Bamberger, E. Ann. 1925, 443, 192.
20. Adams, R.; Stewart, H. W. J. Am. Chem. Soc. 1941, 63, 2859.
21. Ishizumi, K.; Koga, K.; Yamada, S. Chem. Pharm. Bull. 1968, 16, 492.
22. Groves, W. W. British Patents 459,881 and 459,890, 1937. Chem. Abstr. 31, 43469.
23. denHertog, H. J.; Holder, C. R.; Combie, W. P. Reel. Trav. Chim. Pays-Bas 1951, 70, 591.
24. Krall, R. L.; Penry, J. K.; White, B. G.; Kupferberg, H. J. Swinyard, E. A. Epilepsia (N.Y.) 1978, 19, 409.
25. Coughenour, L.; McLean, J. R.; Parker, R. Pharmacol. Biochem. Behav. 1977, 6, 351.
26. McLean, J. R.; Parker, R.; Coughenour, L. Life Sci. 1978, 22, 1067.
27. Litchfield, J. T.; Wilcoxon, F. J. Pharmacol. 1949, 96, 99.